Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events

Statistics in Medicine

Volumn 25, Issue 21, 2006, Pages 3740-3757

  Norén, G Niklas ^a,b   Bate, Andrew ^a   Orre, Roland ^c   Edwards, I Ralph ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c NeuroLogic Sweden AB   (Sweden)

Author keywords

Adverse drug reactions; Exploratory analysis; Pharmacovigilance

Indexed keywords

CAPTOPRIL; KETOCONAZOLE; ORAL POLIOMYELITIS VACCINE; TERFENADINE;

ACCURACY; ARTICLE; BIOSTATISTICS; CARDIOTOXICITY; CONFOUNDING VARIABLE; COUGHING; DATA BASE; DRUG COMPETITION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEART VENTRICLE FIBRILLATION; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MANTEL HAENSZEL TEST; MONTE CARLO METHOD; POLIOMYELITIS; QUANTITATIVE ANALYSIS; RISK FACTOR; SUDDEN INFANT DEATH SYNDROME; WORLD HEALTH ORGANIZATION;

DATABASES, FACTUAL; DRUG TOXICITY; HUMANS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; WORLD HEALTH ORGANIZATION;

EID: 33750336301     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2473     Document Type: Article

References (37)

1. Evans SJ. Pharmacovigilance: a science or fielding emergencies? Statistics in Medicine 2000; 19(23): 3199-3209.
2. Edwards IR. Spontaneous reporting - of what? Clinical concerns about drugs. British Journal of Clinical Pharmacology 1999; 48(2):138-141.
3. Edwards IR. Spontaneous ADR reporting and drug safety signal induction in perspective. To honour Professor Jens Schou. Pharmacology and Toxicology 2000; 86(s1):16-19.
4. Rawlins MD. Spontaneous reporting of adverse drug reactions. I: the data. British Journal of Clinical Pharmacology 1988; 26(1):1-5.
5. Rawlins MD. Spontaneous reporting of adverse drug reactions. II: uses. British Journal of Clinical Pharmacology 1988; 26(1):7-11.
6. Edwards IR, Olsson S. WHO Programme - global monitoring. In Pharmacovigilance, Mann RD, Andrews EB (eds). Wiley: Chichester, 2002; 169-182.
7. Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. European Journal of Clinical Pharmacology 1998; 54: 315-321.
8. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting systems. American Statistician 1999; 54:177-202.
9. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiology and Drug Safety 2001; 10(6):483-486.
10. van der Heijden PG, van Puijenbroek EP, van Buuren S, van der Hofstede JW. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Statistics in Medicine 2002; 21(14):2027-2044.
11. Norwood PK, Sampson AR. A statistical methodology for postmarketing surveillance of adverse drug reaction reports. Statistics in Medicine 1988; 7(10):1023-1030.
12. Praus M, Schindel F, Fescharek R, Schwarz S. Alert systems for post-marketing surveillance of adverse drug reactions. Statistics in Medicine 1993; 12(24):2383-2393.
13. Norén GN, Orre R, Bate A. A hit-miss model for duplicate detection in the WHO drug safety database. Proceedings of the Eleventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 2005; 459-468.
14. Lindquist M, Ståhl M, Bate A, Edwards IR, Meyboom RH. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Safety 2000; 23(6): 533-542.
15. Lindquist M, Edwards IR, Bate A, Fucik H, Nunes AM, Ståhl M. From association to alert - a revised approach to international signal analysis. Pharmacoepidemiology and Drug Safety 1999; 8:15-25.
16. Orre R, Lansner A, Bate A, Lindquist M. Bayesian neural networks with confidence estimations applied to data mining. Computational Statistics and Data Analysis 2000; 34:473-493.
17. Bate A, Lindquist M, Orre R, Edwards IR, Meyboom RH. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. European Journal of Clinical Pharmacology 2002; 58(7):483-490.
18. Ståhl M, Lindquist M, Edwards IR, Brown EG. Introducing triage logic as a new strategy for the detection of signals in the WHO drug monitoring database. Drug Safety 2004; 13(6):355-363.
19. Ståhl M, Edwards IR, Bowring G, Kiuru A, Lindquist M. The usefulness and use of signals from the WHO database by national pharmacovigilance centres - results from a questionnaire. Drug Safety 2003; 26(10): 721-727.
20. Coulter DM, Bate A, Meyboom RH, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. British Medical Journal 2001; 322(7296):1207-1209.
21. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards IR. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365:482-487.
22. Lansner A, Ekeberg Ö. A one-layer feedback artificial neural network with a Bayesian learning rule. International Journal of Neural Systems 1989; 1:77-87.
23. Holst A, Lansner A. A higher order Bayesian neural network for classification and diagnosis. In Applied Decision Technologies: Computational Learning and Probabilistic Reasoning, Gammerman A (ed.). Wiley: New York, 1996; 251-260.
24. Orre R, Lansner A. Pulp quality modelling using Bayesian mixture density neural networks. Journal of Systems Engineering 1996; 6:128-136.
25. Orre R, Bate A, Norén GN, Swahn E, Amborg S, Edwards IR. A Bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets. International Journal of Neural Systems 2005; 15(3):207-222.
26. Norén GN, Orre R. Case based imprecision estimates for Bayes classifiers with the Bayesian bootstrap. Machine Learning 2005; 58:79-94.
27. Norén N. A Monte Carlo method for Bayesian dependency derivation. Master's Thesis, Chalmers University of Technology, 2002.
28. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis (1st edn). Chapman & Hall: London, 1995.
29. Koski T, Orre R. Statistics of the information component in Bayesian neural networks. Technical Report, Department of Numerical Analysis and Computing Science, Royal Institute of Technology, Stockholm, Sweden, 1998.
30. Kenney JF, Keeping ES. Mathematics of Statistics, Pt 1 (3rd edn). Van Nostrand: Princeton, NJ, 1962; 50-54.
31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959; 22:719-748.
32. Gould L. Practical pharmacovigilance analysis strategies. Pharmacoepidemiology and Drug Safety 2003; 12: 559-574.
33. Bate A, Edwards IR, Lindquist M, Orre R. Violation of homogeneity: a methodological issue in the use of data mining tools. The authors' reply. Drug Safety 2003; 26(5):363-366.
34. DuMouchel W, Pregibon D. Empirical Bayes screening for multi-item associations. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 2001; 67-76.
35. Amery WK. Signal generation for spontaneous adverse event reports. Pharmacoepidemiology and Drug Safety 1999; 8:147-150.
36. van Puijenbroek EP, Egberts ACG, Meyboom RHB, Leufkens HGM. Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. British Journal of Clinical Pharmacology 1999; 47:689-693.
37. Yang X, Fram DM. Using disproportional analysis as a tool to explore severe drug-drug interactions in AERS database. Pharmacoepidemiology and Drug Safety 2004; 13(1):S247.